| 产品详情 |
| Edit |   |
| Antigenic Specificity | Serpin A3/alpha 1-Antichymotrypsin |
| Clone | AACT/1452 |
| Host Species | Mouse |
| Reactive Species | human |
| Isotype | IgG1 |
| Format | PE-Atto594 conjugate |
| Size | 0.1 ml |
| Concentration | n/a |
| Applications | Flow Cytometry. Optimal dilution of this antibody should be experimentally determined. For optimal results using our Tandem dyes, please avoid prolonged exposure to light or extreme temperature fluctuations. These can lead to irreversible degradation or decoupling. When staining intracellular targets, specific attention to the fixation and permeabilization steps in your flow protocol may be required. Please contact our technical support team at technical@novusbio.com if you have any questions. |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | The Serpin A3/alpha 1-Antichymotrypsin Antibody (AACT/1452) [PE/Atto594] from Novus Biologicals is a mouse monoclonal antibody to Serpin A3/alpha 1-Antichymotrypsin. This antibody reacts with human. The Serpin A3/alpha 1-Antichymotrypsin Antibody (AACT/1452) [PE/Atto594] has been validated for the following applications: Flow Cytometry. |
| Immunogen | Recombinant human Antichymotrypsin (AACT) protein fragment (aa49-187) (exact sequence is proprietary) |
| Other Names | AACTMGC88254, ACTGIG25, alpha-1-antichymotrypsin, antitrypsin), member 3, Cell growth-inhibiting gene 24/25 protein, growth-inhibiting protein 24, growth-inhibiting protein 25, member 3, serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, serine (or cysteine) proteinase inhibitor, clade A, member 3, Serpin A3, serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin) |
| Gene, Accession # | SERPINA3, Gene ID: 12 |
| Catalog # | NBP2-54438PEATT594 |
| Price | |
| Order / More Info | Serpin A3/alpha 1-Antichymotrypsin Antibody from NOVUS BIOLOGICALS, LLC |
| Product Specific References | n/a |
| 产品资料 |
|
|